Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

VJVirtual | Cell-free DNA liquid biopsy in lung cancer

Geoffrey Oxnard • 9 Apr 2020
General Lung Cancer

Geoffrey Oxnard, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the use of liquid biopsy for identifying resistance mutations to guide therapy decisions. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Geoffrey Oxnard

3:41
Cell-free DNA for multi-cancer detection
Geoffrey Oxnard • 9 Apr 2020
2:54
Impact of COVID-19 on scientific research and treating patients
Geoffrey Oxnard • 9 Apr 2020
1:07
Cell-free DNA sequencing in the clinical setting
Geoffrey Oxnard • 28 Sep 2019
3:19
Cancer detecting and locating: cell-free DNA
Geoffrey Oxnard • 28 Sep 2019

Related Videos

2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
1:47
Assessing follow-up strategies in post-surgical lung cancer: insights from a Phase III trial
Robert Rintoul • 19 Apr 2024
7:37
What is the optimal follow-up for lung cancer long term survivors?
Robert Rintoul • 19 Apr 2024
0:45
Assessing treatment options for lung cancer with interstitial lung disease
Matthew Hatton • 18 Apr 2024
The content of VJOncology is intended for healthcare professionals